Results 1 -
4 of
4
EPIDERMAL GROWTH FACTOR RECEPTOR INDUCES FYN EXPRESSION VIA UP-REGULATION OF P47PHOX IN GLIOBLASTOMA MULTIFORME By
, 2014
"... Part of the Cancer Biology Commons, and the Medicine and Health Sciences Commons This Dissertation (PhD) is brought to you for free and open access by the Graduate School of Biomedical Sciences at ..."
Abstract
- Add to MetaCart
Part of the Cancer Biology Commons, and the Medicine and Health Sciences Commons This Dissertation (PhD) is brought to you for free and open access by the Graduate School of Biomedical Sciences at
REVIEW
, 2014
"... Iron, oxidative stress, and redox signaling in the cardiovascular system ..."
(Show Context)
Review Article The Tumorigenic Roles of the Cellular REDOX Regulatory Systems
, 2015
"... Copyright © 2016 Stéphanie Anáıs Castaldo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The cellular REDOX regulatory syst ..."
Abstract
- Add to MetaCart
(Show Context)
Copyright © 2016 Stéphanie Anáıs Castaldo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The cellular REDOX regulatory systems play a central role in maintaining REDOX homeostasis that is crucial for cell integrity, survival, and proliferation. To date, a substantial amount of data has demonstrated that cancer cells typically undergo increasing oxidative stress as the tumor develops, upregulating these important antioxidant systems in order to survive, proliferate, and metastasize under these extreme oxidative stress conditions. Since a large number of chemotherapeutic agents currently used in the clinic rely on the induction of ROS overload or change of ROS quality to kill the tumor, the cancer cell REDOXadaptation represents a significant obstacle to conventional chemotherapy. In this review we will first examine the different factors that contribute to the enhanced oxidative stress generally observed within the tumormicroenvironment.We will thenmake a comprehensive assessment of the current literature regarding the main antioxidant proteins and systems that have been shown to be positively associated with tumor progression and chemoresistance. Finally we will make an analysis of commonly used chemotherapeutic drugs that induce ROS.The current knowledge of cancer cell REDOX adaptation raises the issue of developing novel and more effective therapies for these tumors that are usually resistant to conventional ROS inducing chemotherapy. 1.